Becker's Healthcare January 15, 2025
Alan Condon

The 340B drug pricing program is a cornerstone for community-based health systems, allowing them to stretch limited resources and provide essential care to uninsured and underinsured patients. However, the program faces mounting challenges that hospital leaders cannot afford to ignore.

For Missionaries of Our Lady Health System, a 10-hospital system headquartered in Baton Rouge, La., the 340B program represents a crucial lifeline.

“It’s a program we’ve continued to take advantage of to support the costs we incur and don’t get reimbursed for — the uninsured and underinsured within our community,” Mr. Gleason said during a Becker’s Healthcare Podcast episode. “It’s worth approximately $150 million annually to our organization and has continued to grow at double-digit percentage rates over the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Provider
The forces that may slow hospital AI growth
Experts publish framework for global adoption of digital health in medical education
HCA Leadership Taking Wait and See Approach to Trump Administration Policies
Top 10 predictions for care at home in 2025
Indiana University Advances Healthcare with Virtual Visits App

Share This Article